Wegovy 1.7 mg contains semaglutide in a once-weekly prescription injection for weight management in eligible adults, used with a reduced-calorie diet and physical activity. The strength forms part of a gradual dose-escalation schedule directed by a clinician. Digestive effects are common, and severe persistent abdominal pain requires urgent medical assessment.